News from volitionrx limited A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-PINK:VNRX,OTC-QB:VNRX)

Dec 02, 2013, 06:30 ET

VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...

Nov 29, 2013, 08:30 ET

VolitionRx to Present at the 6th Annual LD Micro Conference

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...

Nov 14, 2013, 06:30 ET

VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark

VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...

Nov 07, 2013, 06:30 ET

First VolitionRx Study Data Presented at CNAPS, Baltimore

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...

Sep 26, 2013, 06:30 ET

VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...

Sep 03, 2013, 06:30 ET

VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, is...

Jul 22, 2013, 06:30 ET

VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits

VolitionRx Limited (OTC: VNRX), a life sciences company focused on the development of blood-based diagnostic tests, has signed a non-exclusive...

May 01, 2013, 06:30 ET

Racepoint Group Appointed by VolitionRx to Raise Awareness of its new Early-Stage Cancer Diagnostic

VolitionRx Limited (OTC: VNRX), a life sciences company that is developing blood-based diagnostic tests for different types of cancer, has retained...

Apr 04, 2013, 06:30 ET

VolitionRx Files Two Patent Applications

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has filed two...

Mar 26, 2013, 07:00 ET

VolitionRx Hires Head of US Operations, Jason Terrell MD

VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has hired Jason...

Jan 09, 2013, 06:30 ET

VolitionRx Announces Collaboration with Wales Cancer Bank

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a...

Dec 17, 2012, 06:30 ET

Volition Launches NuQ® Epigenetic Immunoassays for Research Use

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces the launch of NuQ®,...

Nov 05, 2012, 06:30 ET

VolitionRx's Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced preliminary...

Aug 21, 2012, 06:30 ET

VolitionRX to Begin Prospective Clinical Trial in Colon Cancer

 VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that its subsidiary Belgian Volition...

Jul 16, 2012, 06:30 ET

VolitionRX Issues CEO Letter to Shareholders

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, issues the following letter to...

Jul 09, 2012, 06:30 ET

VolitionRX Signs Collaboration Agreement With Stefan Holdenrieder of Rheinische Friedrich-Wilhelms-Universitat Bonn Germany

VolitionRX Limited (OTC:VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce that it has...

May 14, 2012, 08:00 ET

VolitionRX Raises Over $1 Million To Begin Clinical Trials of Blood Based Diagnostic Tests

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce the closure...

Mar 27, 2012, 19:01 ET
How VolitionRX's Nucleosomics Technology Works.  (PRNewsFoto/VolitionRX Limited)

Pioneering New Science Nucleosomics Advances Blood Based Diagnostics for Cancer

The ability to diagnose disease early has long been a goal in the medical arena. VolitionRX (VNRX.OB), a life sciences company, is pioneering...

Feb 17, 2012, 05:00 ET

Volition Signs Collaboration Agreement With Abcodia

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, announces a collaboration agreement...

Dec 22, 2011, 07:00 ET

VolitionRX Limited Intellectual Property Update: New Patent Filed

VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce that it has filed...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge